🇺🇸 FDA
Pipeline program

ART0380, ART0380, GEMCITABINE , ART0380, IRINOTECAN , ART0380

ART0380C001

Phase 2 small_molecule active

Quick answer

ART0380, ART0380, GEMCITABINE , ART0380, IRINOTECAN , ART0380 for Advanced or Metastatic Solid Tumours is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Advanced or Metastatic Solid Tumours
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials